Company Filing History:
3 out of 1,586 
1 out of 182 
1 out of 291 
Years Active: 2023-2025
Title: John F Dipersio: Innovator in Gene Editing and Cancer Treatment
Introduction
John F Dipersio is a prominent inventor based in St. Louis, MO (US). He has made significant contributions to the field of gene editing and cancer treatment, holding a total of 3 patents. His work focuses on innovative methods to enhance the efficacy of CAR-T cell therapies for treating T cell malignancies.
Latest Patents
One of his latest patents involves gene editing of CAR-T cells specifically designed for the treatment of T cell malignancies with chimeric antigen receptors. This patent provides methods for utilizing fratricide-resistant CAR-T cells that target antigens expressed by T cell malignancies. Another notable patent outlines methods and compositions for upregulating MHC class II in cancer cells, particularly in hematological cancers. This patent also includes treatment methods for subjects suffering from these cancers, which may be especially beneficial for those who have undergone allogenic transplants or experienced relapses.
Career Highlights
Throughout his career, John F Dipersio has worked with esteemed institutions such as Washington University and The Medical College of Wisconsin, Inc. His research has significantly advanced the understanding and treatment of cancer, particularly through innovative gene editing techniques.
Collaborations
John has collaborated with notable colleagues in his field, including Matthew Christopher and Timothy J Ley. These partnerships have further enriched his research and contributed to the development of groundbreaking therapies.
Conclusion
John F Dipersio is a key figure in the realm of gene editing and cancer treatment, with a focus on CAR-T cell therapies. His innovative patents and collaborations continue to pave the way for advancements in medical science.